[ Inside the business ]

ISRG stock analysis

ISRG · Intuitive Surgical Inc

Orthopedic, prosthetic and surgical appliances and supplies. Growing 22%. Keeps 28¢ of every dollar.

Watch: a leadership change.

The future, in 7 questions

Priced in: 4.8× sales in 5 yrs. Evidence: sales +22% · 28¢ profit/$1.

01 What's priced in?4.8× sales in 5 yrs
Sales now$11.6B
Needed in 5 yrs$55.8B
Backlog$1.7B
02 Is the wave rising?No Radar technology matched

Not among the companies mentioning Radar's technologies most.

03 Will customers keep buying?Sales +22%, steady
No customer over 10%
Backlog $1.7B · 0.1× salesPrepaid $669MSales +22%, steady
04 Is it scarce?Some signs
PricingBacklogPrepaidSell-outTight
05 More profit per sale?Keeps 28¢ per $1, rising
'21'22'23'24'2528¢
Before running costs: 67% → 66%
06 Can it fund itself?Pays its own way
05 yrsself-funded
Shares +0.7%/yrDebt $0
07 What could break it?1 to watch
  • Moves strongly with the S&P 500

From SEC filings, price and Radar. Not advice.

The record

Early signals

Growth speeding up.

Sales growth +23%, +19%, then +22% vs. a year ago. A leadership change was filed on Nov 2.

What could go wrong

Few warning signs.

It has moved 1.3× the market. In the 2008 crisis it fell 72% while the market fell 51%. Debt is covered by cash.

Speculative check

Self-funding.

Passes every condition: profitable, cash-generating and financially sound.

What they sell

59% Instruments and Accessories.

Instruments and Accessories 59% · Systems 25% · Service 16%

Where each dollar goes

28¢ profit.

33¢ to make what it sells, 39¢ on research and overhead, 28¢ left over. Revenue $11.6B in the last 12 months.

Its market

0.6× the economy.

The government expects its industry, converted paper product manufacturing, to grow 1.1% a year to 2035, vs. 2.0% for the whole economy.

Market size and share

Your call.

There's no official size for its market. Enter one you trust to see its share, and slide to see what a bigger share would mean.

Life cycle

Shake-out.

Its cash flows are mixed, typical of a company in transition.

Earnings quality

Clean.

Its numbers don't resemble those of past manipulators. Cash covers 138¢ of each $1 of profit.

Competitive advantage

9 of 10 years.

Returns beat its 10.8% cost of capital in 9 of the last 10 years. Gross margin went from 70% to 66%.

Future bets

13% on research.

$1.5B a year on R&D. $492M on equipment and buildings.

All figures from Intuitive Surgical Inc's SEC filings (EDGAR) unless tagged otherwise. Educational only, not investment advice.